Literature DB >> 9492770

Oral antifungal agents for onychomycosis.

A K Gupta1, R K Scher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9492770     DOI： 10.1016/S0140-6736(05)78552-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.

Authors:  E G Evans; B Sigurgeirsson
Journal:  BMJ       Date:  1999-04-17

2.  A meta-analysis comparing efficacy of continuous terbinafine with intermittent itraconazole for toenail onychomycosis.

Authors:  N A Trivedi; P C Shah
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

3.  Nitric Oxide-Releasing Macromolecule Exhibits Broad-Spectrum Antifungal Activity and Utility as a Topical Treatment for Superficial Fungal Infections.

Authors:  Nathan Stasko; Kimberly McHale; Stanley J Hollenbach; Megan Martin; Ryan Doxey
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

4.  Calcofluor white combination antifungal treatments for Trichophyton rubrum and Candida albicans.

Authors:  Joanne M Kingsbury; Joseph Heitman; Sheldon R Pinnell
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.